Copyright: ©Author(s) 2026.
World J Stem Cells. Jul 26, 2026; 18(7): 118557
Published online Jul 26, 2026. doi: 10.4252/wjsc.118557
Published online Jul 26, 2026. doi: 10.4252/wjsc.118557
Table 2 Antibody information
| Name of antibody | Antibody dilution | Company | Catalog number |
| GSDMD-N | 1:1000 | Abclonal | A22523 |
| Cleaved caspase-1 | 1:500 | Affbiotech | AF4005 |
| IL-1β | 1:2000 | Proteintech Group | 26048-1-AP |
| IL-18 | 1:1000 | Abcam | ab191860 |
| NLRP3 | 1:1000 | Proteintech Group | 68102-1-Ig |
| CD9 | 1:1000 | Proteintech Group | 20597-1-AP |
| CD63 | 1:500 | Affbiotech | AF5117 |
| CD81 | 1:1000 | Abcam | ab109201 |
- Citation: Wu Y, Yin WH, Wang HJ, Cai H. miR-140-3p in exosomes derived from bone-marrow mesenchymal stem cells inhibits pyrotoisosis by targeting PTEN under high-glucose condition. World J Stem Cells 2026; 18(7): 118557
- URL: https://www.wjgnet.com/1948-0210/full/v18/i7/118557.htm
- DOI: https://dx.doi.org/10.4252/wjsc.118557